Skip to main content
. 2023 May 25;9(5):501–507. doi: 10.1002/osp4.686

TABLE 5.

Responses stratified by prescribers and non‐prescribers of obesity medication.

Prescribers (N = 755) Non‐prescribers (N = 413)
Do you refer patients with obesity?
Yes, I refer patients.* 52% 62%
No. I provide counseling and treatment in the office.* 46% 28%
No. I do not have anywhere to refer patients.* 3% 10%
Where do you refer patients with obesity? a
Registered dietician 79% 79%
Obesity specialist* 70% 62%
Face‐to‐face weight loss program* 43% 32%
Community‐based weight loss program 41% 36%
Digital weight loss program* 24% 15%
Somewhere else not listed 7% 9%
My barriers to treating obesity include:
Patients have other higher priority issues 50% 53%
None of the above* 27% 19%
I am not adequately compensated for it 22% 17%
I do not have time to treat obesity* 16% 24%
Obesity is caused by patients themselves* 16% 10%
I am not up‐to‐date on obesity treatments* 14% 25%
Obesity is not a disease* 3% <1%
What barriers do your patients encounter when addressing their obesity?
Inadequate insurance coverage* 66% 51%
Affordability of commercial/digital weight loss programs* 60% 51%
Lack of recognition that obesity is a chronic disease 47% 52%
Lack of access to specialty care for obesity 39% 43%
Availability of grocery stores with fresh, healthful food 37% 38%
Accessibility of commercial/digital weight loss programs 32% 29%
Availability of safe places to exercise 30% 27%
None of the above* 4% 7%
a

Multiple selections.

*p value <0.05 in difference in response between prescribers versus non‐prescribers.